Azra AI has acquired Thynk Health to expand and unify its enterprise imaging workflow automation platform.
Thynk Health's lung cancer screening (LCS) and incidental findings technology will be integrated into Azra AI's enterprise platform for incidental findings and oncology workflow automation to support workflows across radiology, pathology, cardiology, and other service lines, according to the company.
Azra's Clinical Patient Data Layer converts fragmented clinical data into structured, actionable workflows, the company noted. Health systems already using Thynk Health will now have access to Azra AI's full platform.
Financial terms of the deal were not disclosed. However, John Marshall will continue as CEO of the combined organization, and Daniel Weeks, formerly CEO of Thynk Health, will become chief operating officer, the company added.
